Danielsson BR - Search Results

1

Is erythromycin therapy teratogenic in humans?

Källén BA, Otterblad Olausson P, Danielsson BR. Källén BA, et al. Among authors: danielsson br. Reprod Toxicol. 2005 Jul-Aug;20(2):209-14. doi: 10.1016/j.reprotox.2005.01.010. Reprod Toxicol. 2005. PMID: 15907655

2

Use of ondansetron during pregnancy and congenital malformations in the infant.

Danielsson B, Wikner BN, Källén B. Danielsson B, et al. Reprod Toxicol. 2014 Dec;50:134-7. doi: 10.1016/j.reprotox.2014.10.017. Epub 2014 Oct 31. Reprod Toxicol. 2014. PMID: 25450422

3

Fetal safety of erythromycin. An update of Swedish data.

Källén B, Danielsson BR. Källén B, et al. Among authors: danielsson br. Eur J Clin Pharmacol. 2014 Mar;70(3):355-60. doi: 10.1007/s00228-013-1624-3. Epub 2013 Dec 20. Eur J Clin Pharmacol. 2014. PMID: 24352632

4

Erratum to "Use of ondansetron during pregnancy and congenital malformations in the infant" [Reprod. Toxicol. 50C (2017) 134-137].

Danielsson B, Wikner BN, Källén B. Danielsson B, et al. Reprod Toxicol. 2017 Aug;71:176. doi: 10.1016/j.reprotox.2017.06.048. Epub 2017 Jun 23. Reprod Toxicol. 2017. PMID: 28648325 No abstract available.

5

Improved methodology for identifying the teratogenic potential in early drug development of hERG channel blocking drugs.

Nilsson MF, Danielsson C, Sköld AC, Johansson A, Blomgren B, Wilson J, Khan KM, Bengtsson E, Kultima K, Webster WS, Danielsson BR. Nilsson MF, et al. Among authors: danielsson br. Reprod Toxicol. 2010 Apr;29(2):156-63. doi: 10.1016/j.reprotox.2010.01.014. Epub 2010 Feb 6. Reprod Toxicol. 2010. PMID: 20144703

6

Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs.

Danielsson BR, Danielsson C, Nilsson MF. Danielsson BR, et al. Reprod Toxicol. 2007 Jul;24(1):42-56. doi: 10.1016/j.reprotox.2007.04.005. Epub 2007 Apr 27. Reprod Toxicol. 2007. PMID: 17570632 Review.

7

Ondansetron and teratogenicity in rats: Evidence for a mechanism mediated via embryonic hERG blockade.

Danielsson B, Webster WS, Ritchie HE. Danielsson B, et al. Reprod Toxicol. 2018 Oct;81:237-245. doi: 10.1016/j.reprotox.2018.08.018. Epub 2018 Aug 24. Reprod Toxicol. 2018. PMID: 30149139

8

Teratogenicity of the I(Kr)-blocker cisapride: relation to embryonic cardiac arrhythmia.

Sköld AC, Danielsson C, Linder B, Danielsson BR. Sköld AC, et al. Among authors: danielsson c, danielsson br. Reprod Toxicol. 2002 Jul-Aug;16(4):333-42. doi: 10.1016/s0890-6238(02)00042-4. Reprod Toxicol. 2002. PMID: 12220593

9

Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species.

Wellfelt K, Sköld AC, Wallin A, Danielsson BR. Wellfelt K, et al. Among authors: danielsson br. Reprod Toxicol. 1999 Mar-Apr;13(2):93-101. doi: 10.1016/s0890-6238(98)00066-5. Reprod Toxicol. 1999. PMID: 10213516

10

Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism.

Danielsson C, Brask J, Sköld AC, Genead R, Andersson A, Andersson U, Stockling K, Pehrson R, Grinnemo KH, Salari S, Hellmold H, Danielsson B, Sylvén C, Elinder F. Danielsson C, et al. Cardiovasc Res. 2013 Jan 1;97(1):23-32. doi: 10.1093/cvr/cvs296. Epub 2012 Sep 20. Cardiovasc Res. 2013. PMID: 22997158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page